Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

The HslV Protease from Leishmania major and Its Activation by C-terminal HslU Peptides.

Kebe NM, Samanta K, Singh P, Lai-Kee-Him J, Apicella V, Payrot N, Lauraire N, Legrand B, Lisowski V, Mbang-Benet DE, Pages M, Bastien P, Kajava AV, Bron P, Hernandez JF, Coux O.

Int J Mol Sci. 2019 Feb 26;20(5). pii: E1021. doi: 10.3390/ijms20051021.

2.

Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.

Roux L, Priet S, Payrot N, Weck C, Fournier M, Zoulim F, Balzarini J, Canard B, Alvarez K.

Eur J Med Chem. 2013 May;63:869-81. doi: 10.1016/j.ejmech.2013.02.039. Epub 2013 Mar 14.

PMID:
23603046
3.

Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting.

Malcor JD, Payrot N, David M, Faucon A, Abouzid K, Jacquot G, Floquet N, Debarbieux F, Rougon G, Martinez J, Khrestchatisky M, Vlieghe P, Lisowski V.

J Med Chem. 2012 Mar 8;55(5):2227-41. doi: 10.1021/jm2014919. Epub 2012 Feb 14.

PMID:
22257077
4.

Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication.

Barral K, Weck C, Payrot N, Roux L, Durafour C, Zoulim F, Neyts J, Balzarini J, Canard B, Priet S, Alvarez K.

Eur J Med Chem. 2011 Sep;46(9):4281-8. doi: 10.1016/j.ejmech.2011.06.034. Epub 2011 Jul 1.

Supplemental Content

Loading ...
Support Center